A recent article published in Value in Health proposes a new framework for valuing health outcomes in cost-effectiveness analyses and introduces a new metric, health years in total (HYT).
The authors, Anirban Basu et al., write that while the quality-adjusted life year (QALY) metric is an important component of cost-effectiveness analysis, “its potential to be discriminatory towards patients with lower QOL presents a critical challenge.”
“The HYT framework may provide a viable alternative to both the QALY and the EVL; its application to diverse healthcare technologies and stakeholder assessments are important next steps in its development and evaluation,” they write.
To read the article on Value in Health, click here.
Click here to read a press release from ISPOR discussing the article.